Knowledge Hub

Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Press Release   •   Jan 27, 2017 05:00 EST

MarketResearchReports.biz has recently announced the addition of a market study “ Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 ”, is a comparative analysis of the global market.

Global Autologous Cell Therapy Market: Overview

This report provides in-depth region wise and country wise analysis of the autologous cell therapy market. Stakeholders of this report include manufacturers of cell therapy products, raw material suppliers, cancer drug processing companies, and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the global autologous cell therapy market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global autologous cell therapy market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia. Market revenue is provided in terms of US$ Mn from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report provides a snapshot of the autologous cell therapy with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors. Moreover, the report also includes pipeline analysis (phase I & II) of the autologous cell therapy market on basis of disease conditions.

Global Autologous Cell Therapy Market: Drivers and Trends

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global autologous cell therapy market. These factors would aid the stakeholders in establishing a strong foothold in the global autologous cell therapy market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the autologous cell therapy market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Autologous Cell Therapy Market: Segmentation

The autologous cell therapy market has been segmented as source, application, end-user and geography. Based on source, the market has been segmented into bone marrow, epidermis and others. Likewise, on basis of application the market has been categorized into neurology, orthopedic, cancer, wound healing, CVD, autoimmune, and others. Hospitals, ambulatory centers and research centers are included into the market by end-user.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/143277

Global Autologous Cell Therapy Market: Regional Outlook

Geographically, the autologous cell therapy market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the autologous cell therapy market in various regions has been provided in this section.

This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the autologous cell therapy market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market.

Key Players Mentioned in the Report are:

The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include BIOTIME, INC., BrainStorm Cell Therapeutics, Caladrius Biosciences, Inc., Vericel Corporation, Pharmicell Co., Inc., TiGenix N.V., Fibrocell Science, Inc. and Opexa Therapeutics, Inc. among others.

The global autologous cell therapy market has been segmented into:

Global Autologous Cell Therapy Market, by Source

Bone Marrow

Epidermis

Others

Global Autologous Cell Therapy Market, by Application

Neurology

Orthopedic

Cancer

Wound Healing

CVD

Autoimmune

Others

Global Autologous Cell Therapy Market, by End User

Hospitals

Ambulatory Centers

Research Centers

Global Autologous Cell Therapy Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Switzerland

Spain

Rest of Europe

Asia Pacific (APAC)

Japan

China

India

Rest of APAC

Latin America (LATAM)

Brazil

Mexico

Rest of LATAM

Middle East & Africa (MEA)

South Africa

Saudi Arabia

Rest of MEA

Table Of Content

1. Preface

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Objectives

1.4. Key Questions Answered

2. Assumptions and Research Methodology

2.1. Report Assumptions

2.2. Acronyms Used

2.3. Research Methodology

3. Executive Summary

3.1. Global Autologous Cell Therapy Market Snapshot

3.2. Market Opportunity Map

4. Market Overview

4.1. Product Overview

4.2. Key Industry Events

4.3. Death Rate of Leukemia, by Country

4.4. Death Rate of Cancer, by Country

5. Market Dynamics

5.1. Drivers and Restraints Snapshot Analysis

5.2. Drivers

5.3. Restraints

5.4. Opportunities

5.5. Opportunity Analysis

5.6. Pipeline Analysis (Phase I & II)

6. Global Autologous Cell Therapy Market Analysis, by Source

6.1. Key Findings

6.2. Introduction

6.3. Bone Marrow

6.4. Epidermis

6.5. Others

6.6. Key Trends

6.7. Market Attractiveness Analysis